Typically, a promising new experimental drug arrives on the scene with a flourish. But sometimes, it’s a long and winding road.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF scientists Tim Griffin and Albert Batushansky are pushing the bounds of a decades-old scientific method to study the origins of osteoarthritis.
New research from OMRF is taking physicians closer to personalized treatment solutions for patients suffering from lupus.
Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.